For treatment purposes, no studies to date have conclusively shown that adjuvant radioactive iodine therapy can improve this already excellent recurrence risk [13] and ablative doses of this nuclear isotope may be used to facilitate follow-up of thyroglobulin levels as a thyroid cancer marker. This evidence concerns the gene TG and thyroid cancer.